Literature DB >> 27856030

Comparison between Widefield En Face Swept-Source OCT and Conventional Multimodal Imaging for the Detection of Reticular Pseudodrusen.

Karen B Schaal1, Andrew D Legarreta1, William J Feuer1, Giovanni Gregori1, Qianqian Cheng1, John E Legarreta1, Mary K Durbin2, Paul F Stetson2, Sophie Kubach2, Philip J Rosenfeld3.   

Abstract

PURPOSE: The ability to detect reticular pseudodrusen (RPD)/subretinal drusenoid deposits (SDDs) using 12×12-mm widefield en face swept-source optical coherence tomography (SS-OCT) imaging was compared with conventional multimodal imaging (color, fundus autofluorescence (FAF), and infrared reflectance [IR] imaging) in eyes with nonexudative age-related macular degeneration (AMD).
DESIGN: Cross-sectional study. PARTICIPANTS: Patients with nonexudative AMD were prospectively enrolled in an SS-OCT imaging study at the Bascom Palmer Eye Institute.
METHODS: On the same day, all participants underwent color, FAF, and IR fundus imaging, as well as imaging with a prototype Zeiss 100 kHz SS-OCT instrument (Carl Zeiss Meditec Inc, Dublin, CA). Two masked graders assessed the presence, absence, or uncertainty of RPD/SDDs on conventional multimodal images and separately on 4 different SS-OCT en face images derived from the same volumetric dataset. The results from grading the conventional images and the SS-OCT en face images were compared. MAIN OUTCOME MEASURES: Agreement in the detection of RPD/SDDs using different imaging modalities.
RESULTS: A total of 307 eyes (209 patients) were graded for the presence or absence of RPD/SDDs. The agreement between SS-OCT and multimodal imaging was 83%. The difference in RPD/SDD detection with either image modality was not statistically significant (P = 0.21). The sensitivity of SS-OCT in RPD/SDD detection was 83%, and when using conventional imaging, the sensitivity was 75%. When using SS-OCT imaging alone, 10% of RPD/SDD cases would be missed, and when using conventional imaging alone, 14% of RPD/SDD cases would be missed. The presence of RPD/SDD was confirmed retrospectively in 48 of 52 cases once the overall grading was unmasked and the graders reevaluated the conventional multimodal images and the widefield SS-OCT en face images.
CONCLUSIONS: All 4 imaging modalities used together provided the best strategy for the detection of RPD/SDDs. However, when using widefield en face SS-OCT slab imaging alone, the detection of RPD/SDDs was at least as good as conventional imaging.
Copyright © 2016 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27856030     DOI: 10.1016/j.ophtha.2016.10.009

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  Automated drusen detection in dry age-related macular degeneration by multiple-depth, en face optical coherence tomography.

Authors:  Rui Zhao; Acner Camino; Jie Wang; Ahmed M Hagag; Yansha Lu; Steven T Bailey; Christina J Flaxel; Thomas S Hwang; David Huang; Dengwang Li; Yali Jia
Journal:  Biomed Opt Express       Date:  2017-10-17       Impact factor: 3.732

2.  Posterior vitreous detachment in patients with diabetes mellitus.

Authors:  Ken Hayashi; Tatsuhiko Sato; Shin-Ichi Manabe; Akira Hirata; Koichi Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2020-02-11       Impact factor: 2.447

3.  Correlations Between Choriocapillaris and Choroidal Measurements and the Growth of Geographic Atrophy Using Swept Source OCT Imaging.

Authors:  Yingying Shi; Qinqin Zhang; Hao Zhou; Liang Wang; Zhongdi Chu; Xiaoshuang Jiang; Mengxi Shen; Marie Thulliez; Cancan Lyu; William Feuer; Luis de Sisternes; Mary K Durbin; Giovanni Gregori; Ruikang K Wang; Philip J Rosenfeld
Journal:  Am J Ophthalmol       Date:  2020-12-24       Impact factor: 5.258

Review 4.  Spotlight on reticular pseudodrusen.

Authors:  Alessandro Rabiolo; Riccardo Sacconi; Maria Vittoria Cicinelli; Lea Querques; Francesco Bandello; Giuseppe Querques
Journal:  Clin Ophthalmol       Date:  2017-09-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.